ZURICH, March 15 (Reuters) – The largest investor in Swiss drugmaker Galenica is likely to sell its stake soon as the company splits into two separate, publicly listed units, a Swiss newspaper…
The post Galenica chairman says Sprint likely to exit holding – paper appeared first on NASDAQ.